.Pharmacolibrary.Drugs.R_RespiratorySystem.R03D_OtherSystemicDrugsForObstructiveAirwayDiseases.R03DA05_Aminophylline.Aminophylline_2 .Pharmacolibrary.Drugs.R_RespiratorySystem.R03D_OtherSystemicDrugsForObstructiveAirwayDiseases.R03DA05_Aminophylline.Aminophylline_2| name: | Aminophylline_2 |
| ATC code: | R03DA05_2 | route: | oral |
| n-compartments | 1 |
Aminophylline is a bronchodilator consisting of theophylline and ethylenediamine, used in the management of asthma, COPD, and sometimes apnea of prematurity. It is administered orally or intravenously, though use has declined in favor of newer drugs.
PK parameters estimated for oral administration in adults; limited direct PK data for aminophylline, estimates are drawn from theophylline oral PK.
Moore, ES, et al., & Grasela, TH (1989). The population pharmacokinetics of theophylline in neonates and young infants. Journal of pharmacokinetics and biopharmaceutics 17(1) 47–66. DOI:10.1007/BF01059087 PUBMED:https://pubmed.ncbi.nlm.nih.gov/2715932
Karlsson, MO, et al., & Kelman, AW (1991). Population pharmacokinetics of rectal theophylline in neonates. Therapeutic drug monitoring 13(3) 195–200. DOI:10.1097/00007691-199105000-00002 PUBMED:https://pubmed.ncbi.nlm.nih.gov/1926271
Koysooko, R, et al., & Geadsomnuig, S (1987). Pharmacokinetics of oral theophylline in Thai asthmatic children. Asian Pacific journal of allergy and immunology 5(2) 179–185. PUBMED:https://pubmed.ncbi.nlm.nih.gov/3449080